These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 32549350)

  • 1. The Inhibitory Effect of Thioridazine on
    Ahmadi F; Khalvati B; Eslami S; Mirzaii M; Roustaei N; Mazloomirad F; Khoramrooz SS
    Avicenna J Med Biotechnol; 2022; 14(2):132-136. PubMed ID: 35633983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight Into the Anti-staphylococcal Activity of JBC 1847 at Sub-Inhibitory Concentration.
    Ronco T; Kappel LH; Aragao MF; Biagi N; Svenningsen S; Christensen JB; Permin A; Saaby L; Holmstrøm K; Klitgaard JK; Sabat AJ; Akkerboom V; Monaco M; Tinelli M; Friedrich AW; Jana B; Olsen RH
    Front Microbiol; 2021; 12():786173. PubMed ID: 35069485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new phenothiazine derivate is active against Clostridioides difficile and shows low cytotoxicity.
    Ronco T; Aragao FM; Saaby L; Christensen JB; Permin A; Williams AR; Thamsborg SM; Olsen RH
    PLoS One; 2021; 16(10):e0258207. PubMed ID: 34597343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a novel antimicrobial hydrogel for eradication of
    Ronco T; Aragao MF; Svenningsen S; Christensen JB; Permin A; Saaby L; Bionda N; Lantz EE; Olsen RH
    JAC Antimicrob Resist; 2021 Sep; 3(3):dlab108. PubMed ID: 34337409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Lactams against the Fortress of the Gram-Positive
    Fisher JF; Mobashery S
    Chem Rev; 2021 Mar; 121(6):3412-3463. PubMed ID: 33373523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections.
    Bassetti M; Pecori D; Cojutti P; Righi E; Pea F
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1193-1200. PubMed ID: 28988505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Derivative of Thioridazine Shows Low Toxicity and Efficient Activity against Gram-Positive Pathogens.
    Jørgensen NS; Saaby L; Andersson AM; Kromann S; Sheikhsamani E; Permin A; Ronco T; Svenningsen SW; Christensen JB; Olsen RH
    Antibiotics (Basel); 2020 Jun; 9(6):. PubMed ID: 32549350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Promazine Derivative Shows High
    Ronco T; Jørgensen NS; Holmer I; Kromann S; Sheikhsamani E; Permin A; Svenningsen SW; Christensen JB; Olsen RH
    Front Microbiol; 2020; 11():560798. PubMed ID: 33101232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiality of tricyclic compound thioridazine as an effective antibacterial and antiplasmid agent.
    Radhakrishnan V; Ganguly K; Ganguly M; Dastidar SG; Chakrabarty AN
    Indian J Exp Biol; 1999 Jul; 37(7):671-5. PubMed ID: 10522156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).
    Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2008 May; 61(1):86-95. PubMed ID: 18385000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections.
    Fritsche TR; Kirby JT; Jones RN
    Diagn Microbiol Infect Dis; 2004 Jul; 49(3):201-9. PubMed ID: 15246511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.
    Putnam SD; Castanheira M; Moet GJ; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):393-401. PubMed ID: 20022192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro demonstration of intestinal absorption mechanisms of different sugars using 3D organotypic tissues in a fluidic device.
    Marrella A; Buratti P; Markus J; Firpo G; Pesenti M; Landry T; Ayehunie S; Scaglione S; Kandarova H; Aiello M
    ALTEX; 2020; 37(2):255-264. PubMed ID: 31893489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro Antimicrobial Activity of Acne Drugs Against Skin-Associated Bacteria.
    Blaskovich MAT; Elliott AG; Kavanagh AM; Ramu S; Cooper MA
    Sci Rep; 2019 Oct; 9(1):14658. PubMed ID: 31601845
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.